Clinical Trials on Central Nervous System Germ Cell Tumor

Total 90649 results

Jiangsu HengRui Medicine Co., Ltd.

Not yet recruiting

Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors

Advanced Gastroenteropancreatic Neuroendocrine Tumor
Abramson Cancer Center at Penn Medicine
Roswell Park Cancer Institute; CARTI

Recruiting

CapTemY90 for Grade 2 NET Liver Metastases (CapTemY90)

Neuroendocrine Tumors | Neuroendocrine Tumor Grade 2

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

Brain Tumors | Central Nervous System Tumors

United States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
National Cancer Institute (NCI)

Recruiting

Study of Zotiraciclib for Recurrent High-Grade Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Cancer | Brain Tumor

United States
University of Florida
National Institutes of Health (NIH)

Completed

Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors

Glioblastoma | Brain Tumor

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma

Brain Tumor | Central Nervous System Tumor

United States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
European Organisation for Research and Treatment...
NCIC Clinical Trials Group; Trans Tasman Radiation Oncology Group; British Medical...

Completed

Radiation Therapy or Temozolomide in Treating Patients With Gliomas

Brain and Central Nervous System Tumors

France, Spain, Canada, Italy, United Kingdom, Australia, Netherlands, Belgium, Germany, Egypt, Sweden, New Zealand, Israel, Hungary, Singapore, Switzerland, Austria, Luxembourg, Portugal
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

Brain and Central Nervous System Tumors

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

Brain and Central Nervous System Tumors

United States, Canada, Australia, Switzerland, Puerto Rico, Netherlands, New Zealand
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Radiation Therapy Plus Carboplatin and Lobradimil in Treating Children With Newly Diagnosed Brain Stem Gliomas

Brain and Central Nervous System Tumors

United States
Societe Internationale d'Oncologie Pediatrique

Unknown

Carboplatin Plus Vincristine in Treating Children and Adolescents With Low Grade Glioma

Brain and Central Nervous System Tumors

United Kingdom, Italy, Germany
Children's Cancer and Leukaemia Group

Unknown

Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma

Brain and Central Nervous System Tumors

United Kingdom, Ireland
St. Jude Children's Research Hospital

Completed

Vandetanib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Diffuse Brainstem Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas

Brain and Central Nervous System Tumors

United States
Novartis Pharmaceuticals

Active, not recruiting

LUTATHERA Injection General Use Result Survey

Somatostatin Receptor-positive Neuroendocrine Tumor

Japan
Andrei Iagaru

No longer available

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Carcinoid Tumors | Islet Cell (Pancreatic NET) | Other Neuroendocrine Tumors

United States
NCIC Clinical Trials Group

Completed

Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme

Brain and Central Nervous System Tumors

Canada
Rush University Medical Center

Terminated

Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Brain and Central Nervous System Tumors

United States
Jonsson Comprehensive Cancer Center

Completed

Vaccine Therapy in Treating Young Patients Who Are Undergoing Surgery for Malignant Glioma

Brain and Central Nervous System Tumors

United States
NCIC Clinical Trials Group

Completed

Topotecan in Treating Patients With Recurrent Brain Tumors

Brain and Central Nervous System Tumors

Canada
Northwestern University
CTI BioPharma; Cephalon

Unknown

Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI); Jazz Pharmaceuticals

Completed

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Fenretinide in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Gene Therapy in Treating Patients With Recurrent Malignant Gliomas

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Cancer Research UK

Completed

Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

Brain and Central Nervous System Tumors

United Kingdom
European Organisation for Research and Treatment...

Completed

Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme

Brain and Central Nervous System Tumors

France, Italy, Belgium, Netherlands, United Kingdom
National Cancer Institute (NCI)

Completed

CC-5013 in Treating Patients With Recurrent Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma

Brain and Central Nervous System Tumors

United States
Northwestern University
Millennium Pharmaceuticals, Inc.

Completed

Presurgery Bortezomib for Recurrent Malignant Gliomas Followed by Postop Bortezomib & Temozolomide

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Brain and Central Nervous System Tumors

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Temozolomide in Treating Patients With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Brain and Central Nervous System Tumors

United States
Duke University
National Cancer Institute (NCI)

Completed

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

Brain and Central Nervous System Tumors

United States
European Organisation for Research and Treatment...

Completed

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

Brain and Central Nervous System Tumors

France, Switzerland, Italy, Israel, Netherlands, Portugal, Austria, Greece
Pfizer

Completed

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States, Canada
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Thalidomide and Irinotecan in Treating Patients With Glioblastoma Multiforme Who Have Undergone Radiation Therapy

Brain and Central Nervous System Tumors

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Northwestern University
Vion Pharmaceuticals

Terminated

VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma

Brain and Central Nervous System Tumors

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Etoposide Plus Cisplatin in Treating Patients With Recurrent Ependymomas

Brain and Central Nervous System Tumors

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Terminated

Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Duke University

Completed

Carboplatin in Patients With Progressive Gliomas

Brain and Central Nervous System Tumors

United States, Canada
National Cancer Institute (NCI)

Completed

Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

Brain and Central Nervous System Tumors

United States
Erasmus Medical Center

Recruiting

Follow-up After Surgery for Testicular Cancer (FUTURE-testis)

Quality of Life | Testicular Germ Cell Tumor | Testicular Cancer

Netherlands

Clinical Trials on Central Nervous System Germ Cell Tumor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations